0001415889-24-007651.txt : 20240312 0001415889-24-007651.hdr.sgml : 20240312 20240312170216 ACCESSION NUMBER: 0001415889-24-007651 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schall Thomas J. CENTRAL INDEX KEY: 0001423084 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40675 FILM NUMBER: 24743137 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immuneering Corp CENTRAL INDEX KEY: 0001790340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-500-8080 MAIL ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-03122024_090310.xml X0508 4 2024-03-11 0001790340 Immuneering Corp IMRX 0001423084 Schall Thomas J. C/O IMMUNEERING CORPORATION 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 true false false false 0 Stock Option 5.93 2024-03-11 4 A 0 35000 0 A 2034-03-11 Class A Common Stock 35000 35000 D The option vests and becomes exercisable in equal monthly installments over a three year period commencing on April 11, 2024, and will be fully vested and exercisable on March 11, 2027. /s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall 2024-03-12